GT Biopharma, Inc. (GTBP)
0.6638
-0.02
(-2.38%)
USD |
NASDAQ |
Jan 30, 16:00
0.6735
+0.01
(+1.46%)
After-Hours: 20:00
GT Biopharma Total Assets (Quarterly) : 4.321M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| SELLAS Life Sciences Group, Inc. | 51.56M |
| Lyell Immunopharma, Inc. | 407.96M |
| Geron Corp. | 567.38M |
| Regeneron Pharmaceuticals, Inc. | 40.17B |
| Crinetics Pharmaceuticals, Inc. | 1.196B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.321M |
| Shareholders Equity (Quarterly) | 3.00M |
| Current Ratio | 2.696 |